About this trial
The goal of this clinical trial is to assess differences in residual gastric volumes after stopping Miralax ingestion at different time points (1-4 hours) prior to anesthesia induction.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients undergoing both EGD and colonoscopy
Use of Miralax for cleanout
Patients <19 years old
Disqualifiers
Patients with a history of delayed gastric emptying (eg diabetic, GLP-1 intake)
Patients with a history of gastric sleeve surgery
Use of Golytely for cleanout
Emergent EGD/colonoscopies
Trial design
Parallel
Treatments tested in this trial
Stopping Miralax ingestion 4 hours prior to anesthesia induction
BehavioralStopping Miralax ingestion 4 hours prior to anesthesia induction
Stopping Miralax ingestion 3 hours prior to anesthesia induction
BehavioralStopping Miralax ingestion 3 hours prior to anesthesia induction
Stopping Miralax ingestion 2 hours prior to anesthesia induction
BehavioralStopping Miralax ingestion 2 hours prior to anesthesia induction
Stopping Miralax ingestion 1 hour prior to anesthesia induction
BehavioralStopping Miralax ingestion 1 hour prior to anesthesia induction
Treatment groups
Trial outcomes
Primary outcomes
Residual gastric volume as measured by EGD
Secondary outcomes
Preoperative gastric POCUS volume assessment
Effectiveness of colonoscopy cleanout
The effectiveness of colonoscopy cleanout will be assessed by the Boston Bowel Preparation Scale (BBPS).
Incidence of aspiration on induction and perioperative aspiration
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: